Indiana leads the nation in medicating those with autism. With the national average at 41%, Indiana treats 1 out of every 2 patients with medication. Indiana also spends less than the national average in treatments for autism.

Affecting 1:4000 males and 1:6000 females, Fragile X is the most common inherited cause of intellectual disability. To combat this, clinical trials will soon be taking place to test medication that may aid in correcting a central neurochemical defect underlying Fragile X syndrome.

Many that are affected by autism have benefited with the prescribed use of psychotropic drugs. But at what price? Recent studies show that in many cases the medications can have a negative impact on overall health due to weight gain.

More and more findings are showing that autism is not just a neurological disorder but one that affects more areas of the body than first suspected. Findings in the gut and the immune system have also been noted. Teams of neuroscientists, toxicologists and other professionals are combing over findings in many areas including food allergies, abnormal placenta growth and inflamed brain tissue to come with viable medications that may assist in aiding autism.

Recently making national news, Celexa has been proven to be ineffective at treating symptoms of autism such as repetitive behaviors such as spinning, head banging, and twirling. In many instances those taking Celexa were twice as likely to develop repetitive behaviors than those on a placebo. Many also suffered side effects such as nightmares.